139 related articles for article (PubMed ID: 23754547)
1. Prognosis in women with breast cancer and private extra insurance coverage.
Grau JJ; Zanon G; Caso C; Gonzalez X; Rodriguez A; Caballero M; Biete A
Ann Surg Oncol; 2013 Sep; 20(9):2822-7. PubMed ID: 23754547
[TBL] [Abstract][Full Text] [Related]
2. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
White R; Dinneen T; Makris A
Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
[TBL] [Abstract][Full Text] [Related]
3. Physical activity and survival of postmenopausal, hormone receptor-positive breast cancer patients: results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle study.
de Glas NA; Fontein DB; Bastiaannet E; Pijpe A; De Craen AJ; Liefers GJ; Nortier HJ; de Haes HJ; van de Velde CJ; van Leeuwen FE
Cancer; 2014 Sep; 120(18):2847-54. PubMed ID: 24840230
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
5. Patterns of care with regard to surgical choice and application of adjuvant radiation therapy for preinvasive and early stage breast cancer in rural Appalachia.
Freeman AB; Huang B; Dragun AE
Am J Clin Oncol; 2012 Aug; 35(4):358-63. PubMed ID: 21422902
[TBL] [Abstract][Full Text] [Related]
6. Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer.
Rueth NM; Black DM; Limmer AR; Gabriel E; Huo L; Fornage BD; Dogan BE; Chavez-MacGregor M; Yi M; Hunt KK; Strom EA
Ann Surg Oncol; 2015 Jan; 22(1):90-5. PubMed ID: 25249256
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Stitt L
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):117-23. PubMed ID: 9747828
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED).
Juan O; Lluch A; de Paz L; Prósper F; Azagra P; Marugán I; Martínez-Agulló A; Garcia-Conde J
Breast Cancer Res Treat; 1999 Jan; 53(2):105-12. PubMed ID: 10326787
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival.
Tarhan MO; Demir L; Somali I; Yigit S; Erten C; Alacacioglu A; Ellidokuz H; Seseogullari O; Kucukzeybek Y; Can A; Dirican A; Bayoglu V; Akyol M
Clin Exp Metastasis; 2013 Feb; 30(2):201-13. PubMed ID: 22915160
[TBL] [Abstract][Full Text] [Related]
10. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
[TBL] [Abstract][Full Text] [Related]
11. Stage 0 to stage III breast cancer in young women.
Gajdos C; Tartter PI; Bleiweiss IJ; Bodian C; Brower ST
J Am Coll Surg; 2000 May; 190(5):523-9. PubMed ID: 10801018
[TBL] [Abstract][Full Text] [Related]
12. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
Willner J; Kiricuta IC; Kölbl O
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
[TBL] [Abstract][Full Text] [Related]
13. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
[TBL] [Abstract][Full Text] [Related]
14. Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: clinicopathological features, efficacy, and factors affecting survival.
Ulas A; Kos T; Avci N; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
Asian Pac J Cancer Prev; 2015; 16(4):1643-9. PubMed ID: 25743846
[TBL] [Abstract][Full Text] [Related]
15. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Tausch C; Taucher S; Dubsky P; Seifert M; Reitsamer R; Kwasny W; Jakesz R; Fitzal F; Filipcic L; Fridrik M; Greil R; Gnant M
Ann Surg Oncol; 2012 Jun; 19(6):1808-17. PubMed ID: 22207051
[TBL] [Abstract][Full Text] [Related]
17. Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?
Aurilio G; Bagnardi V; Graffeo R; Nolè F; Petit JY; Locatelli M; Martella S; Iera M; Rey P; Curigliano G; Rotmensz N; Munzone E; Goldhirsch A
Anticancer Res; 2014 Nov; 34(11):6677-83. PubMed ID: 25368274
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Venkatesan V; Dar AR; Stitt L
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):541-50. PubMed ID: 9231678
[TBL] [Abstract][Full Text] [Related]
19. Medial tumor localization in breast cancer--an unappreciated risk factor?
Bräutigam E; Track C; Seewald DH; Feichtinger J; Spiegl K; Hammer J
Strahlenther Onkol; 2009 Oct; 185(10):663-8. PubMed ID: 19806331
[TBL] [Abstract][Full Text] [Related]
20. First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research.
Borner M; Bacchi M; Goldhirsch A; Greiner R; Harder F; Castiglione M; Jungi WF; Thürlimann B; Cavalli F; Obrecht JP
J Clin Oncol; 1994 Oct; 12(10):2071-7. PubMed ID: 7931476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
